Last week, the FDA accused Novo Nordisk of failing to develop proper procedures for reporting on side effects related to these popular diabetes and weight loss drugs
GLP-1 receptor agonists and gastrointestinal adverse events
The results from a large retrospective cohort study of 81,573 patients with T2D in the United Kingdom between 2004 and 2006, with follow-up until 2011, showed that the median time to intensification with insulin was 7.1, 6.1, and 6.0 years for those taking 1, 2, or 3 oral glucose-lowering agents, and mean glycated hemoglobin (HbA1c) was 8.7, 9.1, and 9.7%, respectively [19]
While an overactive thyroid can deplete your body's structural proteins, high-quality collagen peptides offer a way to support your bones, muscles, and skin without interfering with your medication
Urinary neutrophil gelatinase associated lipocalins (NGALs) predict acute kidney injury post liver transplant
There are also numerous anecdotal stories of people taking semaglutide alongside an SSRI, and either having contradictory effects or cumulative effects